Adient (ADNT) FY2025 results: revenue $14.5 billion, down 1.0% on the year
Adient plc (ADNT) reported revenue of $14.5 billion for fiscal 2025, the year ended 30 September 2025, down 1.0% on the year before. Net income was -$281 million, and diluted earnings per share $-3.39. The figures are the company's own, from the 10-K it filed with the SEC on 18 November 2025.
Revenue
$14.5 billion
-1.0% on the year
FY2018FY2025
Operating margin
n/a
FY2018FY2025
Net income
-$281 million
FY2018FY2025
Diluted EPS
-$3.39
FY2018FY2025
this yearthe year beforeHover a bar for its figure.
The year in brief
What management said about the year
Quarter sales rose, adjusted EBITDA fell: Net sales were $3,688 million against $3,562 million for the three months, and adjusted EBITDA was $226 million against $235 million. The adjusted EBITDA margin was 6.1% against 6.6%.
Quarter net income and EPS fell: Net income attributable to Adient was $18 million against $79 million a year earlier. Diluted EPS was $0.22 against $0.91.
Twelve-month net loss and restructuring charges: For the twelve months, net loss attributable to Adient was $281 million, with diluted loss per share of $3.39, against $18 million of net income and $0.20 diluted EPS a year earlier.
Asia margin fell to 13.5%: Asia adjusted EBITDA was $106 million against $112 million, a 13.5% margin against 14.6%. Asia had the highest segment margin in both three-month periods shown.
Free cash flow fell in quarter: Free cash flow, defined as operating cash flow less capital expenditures, was $134 million against $191 million in the quarter, and $204 million against $277 million for the twelve months.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2025
FY2024
FY2023
On the year
Last 8 years
Operating cash flow
449
543
667
-17.3%
Capital expenditure
245
266
252
-7.9%
Free cash flow
204
277
415
-26.4%
Free cash flow margin
1.4%
1.9%
2.7%
Cash from investing
-186
-253
-229
Cash from financing
-267
-502
-271
Depreciation and amortisation
325
332
340
-2.1%
Share-based compensation
32.0
31.0
34.0
+3.2%
Buybacks
125
275
65.0
-54.5%
Diluted shares, weighted
83m
90m
95m
-7.9%
Shares outstanding at period end
79m
85m
94m
-6.7%
Balance sheet
$ million
FY2025
FY2024
FY2023
On the year
Last 8 years
Shareholders' equity
1,766
2,134
2,228
-17.2%
Non-controlling interest
297
309
318
-3.9%
Short-term borrowings
2.0
1.0
n/a
+100.0%
Debt
2,386
2,396
2,535
-0.4%
Operating lease liabilities
176
168
163
+4.8%
Other liabilities
4,327
4,343
4,180
-0.4%
Total liabilities and equity
8,954
9,351
9,424
-4.2%
Fixed assets
1,409
1,410
1,382
-0.1%
Goodwill
1,807
2,164
2,094
-16.5%
Intangible assets
319
371
408
-14.0%
Cash and equivalents
958
945
1,110
+1.4%
Inventory
695
758
841
-8.3%
Other assets
3,766
3,703
3,589
+1.7%
Total assets
8,954
9,351
9,424
-4.2%
10-K for the year ended 30 September 2025, filed 18 November 2025: the filing.